Darbepoetin Alfa MDS Companion Protocol
NCT02175277
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndrome (MDS)
Interventions
DRUG:
Darbepoetin Alfa
Sponsor
Amgen